AUTL vs KEY · rev $10.1M vs P/E 13, rev $7.51B
Autolus Therapeutics Ltd (AUTL) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported AUTL revenue for 2024-12-31 was $10.1M. Net income was -$220.7M. Revenue was up 496.0% from 2023-12-31 to 2024-12-31. AUTL currently screens at market cap $614.8M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
AUTL currently screens at market cap $614.8M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the AUTL and KEY stock pages for the full models.
Not investment advice.